ATPR regulates human mantle cell lymphoma cells differentiation via SOX11/CyclinD1/Rb/E2F1

被引:3
作者
Xu, Xiaoling [1 ,2 ]
Zhang, Tao [1 ,2 ]
Zhang, Meiju [1 ,2 ]
Li, Lanlan [1 ,2 ]
Deng, Ge [1 ,2 ]
Lu, Zheng [1 ,2 ]
Zhang, Zhenyu [1 ,2 ]
Du, Yan [1 ,2 ]
Feng, Yubin [1 ,2 ]
Feng, Xiaowen [1 ,2 ]
Peng, Xiaoqing [3 ]
Chen, Feihu [1 ,2 ]
机构
[1] Anhui Med Univ, Anhui Inst Innovat Drugs, Sch Pharm, Key Lab Inflammat, Hefei, Anhui, Peoples R China
[2] Minist Educ, Key Lab Antiinflammatory & Immune Med, Hefei, Anhui, Peoples R China
[3] Anhui Med Univ, Dept Obstet & Gynecol, Affiliated Hosp 1, Hefei, Anhui, Peoples R China
关键词
Mantle cell lymphoma; 4-amino-2-trifluoromethyl-phenyl retinate; SOX11; Differentiation; CyclinD1; Rb; TRANS-RETINOIC ACID; CYCLE ARREST; PROMOTER METHYLATION; TRANSCRIPTION FACTOR; IN-VITRO; SOX11; CANCER; PROLIFERATION; EXPRESSION; APOPTOSIS;
D O I
10.1016/j.cellsig.2022.110280
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Mantle cell lymphoma (MCL) is a lymphoproliferative disorder that lacks reliable therapeutic options. Therefore, new treatment approaches for targeting novel biological pathways are required. 4-amino-2-trifluoromethylphenyl retinate (ATPR) synthesized by our group previously has been proven to have higher solubility and superior differentiation effects compared to those of conventional all-trans retinoic acid in acute myeloid leukemia. ATPR induces differentiation and inhibits the proliferation of acute promyelocytic leukemia. However, whether ATPR induces differentiation of MCL cells to normal immune cells has not been investigated. In this study, the proliferation of JEKO-1 cells was completely repressed, and differentiation was activated after ATPR treatment. The neural transcription factor SOX11 was further found to be highly expressed in MCL, but was downregulated by ATPR. After silencing SOX11 in vitro and in vivo, the malignant proliferation and inhibited differentiation of JEKO-1 cells were reversed, whereas the overexpression of SOX11 exacerbated the malignant phenotype of JEKO-1 cells. We also have added additional MCL cell lines (MINO) to complete the key pilot experiments. In addition, the CyclinD1/Rb/E2F1 axis was involved in MCL and was regulated by ATPR. In conclusion, ATPR promoted JEKO-1 cell differentiation via SOX11/CyclinD1/Rb/E2F1. This study provides experimental foundation for developing differentiation therapy for MCL with ATPR.
引用
收藏
页数:12
相关论文
共 50 条
[31]   Largazole Arrests Cell Cycle at G1 Phase and Triggers Proteasomal Degradation of E2F1 in Lung Cancer Cells [J].
Wu, Li-Chuan ;
Wen, Zhe-Sheng ;
Qiu, Ya-Tao ;
Chen, Xiao-Qin ;
Chen, Hao-Bin ;
Wei, Ming-Ming ;
Liu, Zi ;
Jiang, Sheng ;
Zhou, Guang-Biao .
ACS MEDICINAL CHEMISTRY LETTERS, 2013, 4 (10) :921-926
[32]   miRNA-205 Suppresses Melanoma Cell Proliferation and Induces Senescence via Regulation of E2F1 Protein [J].
Dar, Altaf A. ;
Majid, Shahana ;
de Semir, David ;
Nosrati, Mehdi ;
Bezrookove, Vladimir ;
Kashani-Sabet, Mohammed .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (19) :16606-16614
[33]   miR-329-3p regulates neural stem cell proliferation by targeting E2F1 [J].
Lin, Dapeng ;
Shi, Yao ;
Hu, Yiwen ;
Du, Xiaowen ;
Tu, Guanjun .
MOLECULAR MEDICINE REPORTS, 2019, 19 (05) :4137-4146
[34]   Dyrk1a regulates the cardiomyocyte cell cycle via D-cyclin-dependent Rb/E2f-signalling [J].
Hille, Susanne ;
Dierck, Franziska ;
Kuehl, Constantin ;
Sosna, Justyna ;
Adam-Klages, Sabine ;
Adam, Dieter ;
Luellmann-Rauch, Renate ;
Frey, Norbert ;
Kuhn, Christian .
CARDIOVASCULAR RESEARCH, 2016, 110 (03) :381-394
[35]   miR-149*Induces Apoptosis by Inhibiting Akt1 and E2F1 in Human Cancer Cells [J].
Lin, Ruey-Jen ;
Lin, You-Chin ;
Yu, Alice L. .
MOLECULAR CARCINOGENESIS, 2010, 49 (08) :719-727
[36]   E2F1 Reduces Sorafenib's Sensitivity of Esophageal Carcinoma Cells via Modulating the miR-29c-3p/COL11A1 Signaling Axis [J].
Ma, Zhifeng ;
Zhu, Ting ;
Wang, Haiyong ;
Wang, Bin ;
Fu, Linhai ;
Yu, Guangmao .
CURRENT MOLECULAR PHARMACOLOGY, 2024, 17
[37]   Mechanism of E2F1 in the proliferation, migration, and invasion of endometrial carcinoma cells via the regulation of BMI1 transcription [J].
Lu, Yanyang ;
Wei, Ying ;
Shen, Xiaoqin ;
Tong, Yixi ;
Lu, Jin ;
Zhang, Yahui ;
Ma, Yun ;
Zhang, Rong .
GENES & GENOMICS, 2023, 45 (11) :1423-1431
[38]   Transcriptional factor E2F1 inhibits expression of the cellular repressor of E1A-stimulated genes and regulates VSMCs differentiation in vitro [J].
Han Ya-Ling ;
Zhao Xin ;
Yan Cheng-Hui ;
Kang Jian ;
Zhang Xiao-Lin ;
Deng Jie ;
Xu Hong-Mei ;
Liu Hai-Wei .
PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2007, 34 (05) :490-496
[39]   E2F1 Suppresses Oxidative Metabolism and Endothelial Differentiation of Bone Marrow Progenitor Cells [J].
Xu, Shiyue ;
Tao, Jun ;
Yang, Liu ;
Zhang, Eric ;
Boriboun, Chan ;
Zhou, Junlan ;
Sun, Tianjiao ;
Cheng, Min ;
Huang, Kai ;
Shi, Jiawei ;
Dong, Nianguo ;
Liu, Qinghua ;
Zhao, Ting C. ;
Qiu, Hongyu ;
Harris, Robert A. ;
Chandel, Navdeep S. ;
Losordo, Douglas W. ;
Qin, Gangjian .
CIRCULATION RESEARCH, 2018, 122 (05) :701-711
[40]   E2F1 Induces KIF26A Transcription and Promotes Cell Cycle Progression via CDK-RB-E2Fs Feedback Loop in Breast Cancer [J].
Xu, Jing ;
Liu, Lei ;
Ma, Ranran ;
Wang, Yawen ;
Chen, Xu ;
Liu, Haiting ;
Ji, Youxin ;
Liu, Tiantian ;
Gao, Peng .
FRONTIERS IN ONCOLOGY, 2021, 10